Immunovant Inc (IMVT)

Finanzdaten der Immunovant Inc-Aktie (IMVT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	0.48%160.32	159.55	114.36	131.76	127.22
Income/Loss From Continuing Operations Before Tax	1.67%-153.22	-150.70	-109.08	-125.91	-119.70
Income Tax Expense/Benefit	100.00%-	-2.84	1.55	0.59	0.91
	3.63%-153.22	-147.86	-110.64	-126.50	-120.61
Attributable To Parent	3.63%-153.22	-147.86	-110.64	-126.50	-120.61
Basic Average Shares	205.55	-	181.51	173.64	170.87
Diluted Average Shares	205.55	-	181.51	173.64	170.87
Basic Earnings Per Share	-0.75	-	-0.61	-0.73	-0.71
Diluted Earnings Per Share	-0.75	-	-0.61	-0.73	-0.71